Cargando…

Cardiovascular risk factors early in the course of treatment in people with type 2 diabetes without established cardiovascular disease: A population‐based observational retrospective cohort study

AIMS: To characterise the cardiovascular risk of people with type 2 diabetes without established cardiovascular disease but with risk factors, relative to those with established cardiovascular disease, to provide information on which patients could benefit from early use of glucose‐lowering therapie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khunti, Kamlesh, Hertz, Christin L., Husemoen, Lise Lotte N., Mocevic, Emina, Nordsborg, Rikke B., Piltoft, Johanne S., Bain, Stephen C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research: Complications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293142/ https://www.ncbi.nlm.nih.gov/pubmed/34558105 http://dx.doi.org/10.1111/dme.14697

Ejemplares similares

Cardiovascular Autonomic Neuropathy and Subclinical Cardiovascular Disease in Normoalbuminuric Type 1 Diabetic Patients
por: Mogensen, Ulrik Madvig, et al.
Publicado: (2012)

Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality
por: Selvin, Elizabeth, et al.
Publicado: (2016)

Baroreflex Sensitivity Impairment During Hypoglycemia: Implications for Cardiovascular Control
por: Rao, Ajay D., et al.
Publicado: (2016)

Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes: A 6-Year Cohort Study
por: Ricks, Joni, et al.
Publicado: (2012)

Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-Year Follow-Up Study
por: Nin, Johanna W.M., et al.
Publicado: (2010)

Glycation of LDL by Methylglyoxal Increases Arterial Atherogenicity: A Possible Contributor to Increased Risk of Cardiovascular Disease in Diabetes
por: Rabbani, Naila, et al.
Publicado: (2011)

Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes
por: Wretlind, Asger, et al.
Publicado: (2023)

Serum Vascular Adhesion Protein-1 Predicts 10-Year Cardiovascular and Cancer Mortality in Individuals With Type 2 Diabetes
por: Li, Hung-Yuan, et al.
Publicado: (2011)

The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study
por: Matsushita, Kunihiro, et al.
Publicado: (2010)

Higher frequency of cardiovascular autonomic neuropathy in youth with type 2 compared to type 1 diabetes: Role of cardiometabolic risk factors
por: Varley, Benjamin J., et al.
Publicado: (2022)

Relationship of Glycated Albumin to Blood Glucose and HbA(1c) Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study
por: Nathan, David M., et al.
Publicado: (2014)

Uncoupling Endothelial Nitric Oxide Synthase Is Ameliorated by Green Tea in Experimental Diabetes by Re-establishing Tetrahydrobiopterin Levels
por: Faria, Aline M., et al.
Publicado: (2012)

Glycated Hemoglobin and the Risk of Kidney Disease and Retinopathy in Adults With and Without Diabetes
por: Selvin, Elizabeth, et al.
Publicado: (2011)

Consistent Effects of Hypoglycemia on Cognitive Function in People With or Without Diabetes
por: Verhulst, Clementine E.M., et al.
Publicado: (2022)

Accelerated Progression From Mild Cognitive Impairment to Dementia in People With Diabetes
por: Xu, Weili, et al.
Publicado: (2010)

Resting-State Brain Networks in Type 1 Diabetic Patients With and Without Microangiopathy and Their Relation to Cognitive Functions and Disease Variables
por: van Duinkerken, Eelco, et al.
Publicado: (2012)

Insulin Resistance, Defective Insulin-Mediated Fatty Acid Suppression, and Coronary Artery Calcification in Subjects With and Without Type 1 Diabetes: The CACTI Study
por: Schauer, Irene E., et al.
Publicado: (2011)

Association Between Impaired Cardiovascular Autonomic Function and Hypoglycemia in Patients With Type 1 Diabetes
por: Jaiswal, Mamta, et al.
Publicado: (2014)

Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Bjerre-Christensen, Theis, et al.
Publicado: (2021)

Correlation of global risk assessment with cardiovascular complications in patients with diabetes mellitus living in Puerto Rico
por: Rodríguez-Vigil, Efraín, et al.
Publicado: (2016)

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS
por: Koshino, Akihiko, et al.
Publicado: (2022)

Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
por: Berthier, Celine C., et al.
Publicado: (2009)

Progression of Cardiovascular Autonomic Dysfunction in Patients With Type 2 Diabetes: A 7-year follow-up study
por: Ko, Seung-Hyun, et al.
Publicado: (2008)

Cardiovascular risk factors from diagnosis in children with type 1 diabetes mellitus: a longitudinal cohort study
por: Jones, Stephanie, et al.
Publicado: (2019)

Bone turnover and metabolite responses to exercise in people with and without long-duration type 1 diabetes: a case–control study
por: Taylor, Guy S, et al.
Publicado: (2020)

Circulating Palmitoyl Sphingomyelin Is Associated With Cardiovascular Disease in Individuals With Type 2 Diabetes: Findings From the China Da Qing Diabetes Study
por: Chen, Yanyan, et al.
Publicado: (2022)

Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi‐ethnic population
por: Coles, Briana, et al.
Publicado: (2020)

All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK
por: Husemoen, Lise Lotte Nystrup, et al.
Publicado: (2021)

The Cross-sectional and Longitudinal Associations of Diabetic Retinopathy With Cognitive Function and Brain MRI Findings: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
por: Hugenschmidt, Christina E., et al.
Publicado: (2014)

Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom
por: Feher, Michael, et al.
Publicado: (2017)

Association of the IgG N-glycome with the course of kidney function in type 2 diabetes
por: Singh, Sunny S, et al.
Publicado: (2020)

MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34(+) Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia
por: Spinetti, Gaia, et al.
Publicado: (2020)

Neuronatin: A New Inflammation Gene Expressed on the Aortic Endothelium of Diabetic Mice
por: Mzhavia, Nino, et al.
Publicado: (2008)

Potent Inhibition of Cicatricial Contraction in Proliferative Vitreoretinal Diseases by Statins
por: Kawahara, Shuhei, et al.
Publicado: (2008)

Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype
por: Asleh, Rabea, et al.
Publicado: (2008)

Sulfasalazine Blocks the Development of Tactile Allodynia in Diabetic Rats
por: Berti-Mattera, Liliana N., et al.
Publicado: (2008)

Activation of NF-E2–Related Factor-2 Reverses Biochemical Dysfunction of Endothelial Cells Induced by Hyperglycemia Linked to Vascular Disease
por: Xue, Mingzhan, et al.
Publicado: (2008)

Impaired Collateral Recruitment and Outward Remodeling in Experimental Diabetes
por: van Golde, Jolanda M., et al.
Publicado: (2008)

Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice
por: Ku, Ching-Hsin, et al.
Publicado: (2008)

Diffusion Tensor Imaging Identifies Deficits in White Matter Microstructure in Subjects With Type 1 Diabetes That Correlate With Reduced Neurocognitive Function
por: Kodl, Christopher T., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_fjrh258knfnhuka1fek6bbcv8r